Position in RZLT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,903,017
+$656,748 QoQ
Shares Held
951,809
0.0% QoQ
Ownership
0.988%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GREAT POINT PARTNERS LLC holds $375,251,240 across 36 Biotechnology names. RZLT ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
374,000 | $31,479,580 | |
| 2 | VOR |
Vor Biopharma Inc.
|
1,750,000 | $31,220,000 | |
| 3 | ZURA |
Zura Bio Ltd
|
4,215,930 | $25,084,783 | |
| 4 | NKTR |
Nektar Therapeutics
|
316,453 | $22,768,793 | |
| 5 | SLGL |
Sol-Gel Technologies Ltd.
|
274,363 | $21,735,036 | |
| 6 | ALMS |
Alumis Inc.
|
856,061 | $18,859,023 | |
| 7 | DRUG |
Bright Minds Biosciences Inc.
|
220,000 | $16,053,400 | |
| 8 | ANNX |
Annexon, Inc.
|
2,500,000 | $13,850,000 |
All Filings in RZLT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,903,017 | 951,809 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,246,269 | 951,809 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,047,004 | 2,451,809 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,529,240 | 3,033,462 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,415,821 | 833,042 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,047,280 | 621,894 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||